InvestorsHub Logo
Followers 129
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

Re: None

Monday, 10/28/2019 8:36:49 AM

Monday, October 28, 2019 8:36:49 AM

Post# of 14303
Q3 2019 Revenues of $1.87 million, a 13% sequential increase over Q2 2019, and a 0.6% decrease compared to Q3 2018

Q3 2019 Gross Profit of $873,000, representing 46.7% of revenues, a sequential increase of 168% over Q2 2019, and an 86% increase over Q3 2018

Operating Loss in Q3 2019 decreased by $1.25 million to $2.8 million, a sequential decline of 48% compared to Q2 2019 and a 31% decrease compared to Q3 2018

Dario demonstrated strategic interest in its platform with potential revenue generating possibly beginning in the first half of 2020, Dance Biopharma partnership and exciting pipeline of potential additional opportunities

Results reflect and support Dario's strategic push into business-to-business (B2B), as sequential revenue growth and client wins were generated in combination with a lower expense structure
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DRIO News